Reason for request

Inclusion

-


Clinical Benefit

Substantial

The actual benefit is substantial in the indication in the Marketing Authorisation.


Clinical Added Value

no clinical added value

DEXDOR does not offer any improvement in actual benefit (non-existent IAB) in comparison with propofol and midazolam in the light to moderate sedation of adults in intensive care units.


Contact Us

Évaluation des médicaments